M&A Deal Summary

Recordati Acquires Opalia Pharma S.A.

On November 1, 2013, Recordati acquired healthcare services company Opalia Pharma S.A. from The Abraaj Group

Acquisition Highlights
  • This is Recordati’s 2nd transaction in the Healthcare Services sector.
  • This is Recordati’s 1st transaction in Tunisia.

M&A Deal Summary

Date 2013-11-01
Target Opalia Pharma S.A.
Sector Healthcare Services
Buyer(s) Recordati
Sellers(s) The Abraaj Group
Deal Type Add-on Acquisition

Target

Opalia Pharma S.A.

Tunisia
Opalia Pharma is a pharmaceutical company manufacturing generics under the brand name of Opalia. Its sales mainly cover the Tunisian market, with exports to Francophone Sub-Saharan Africa, North Africa and the Middle East. Opalia has a portfolio of around 130 products and holds approximately 120 drug registrations for the Tunisian market.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Recordati

Milan, Italy

Category Company
Founded 1926
Sector Medical Products
Employees4,455
Revenue 2.1B EUR (2023)
DESCRIPTION

Recordati is an international pharmaceutical group dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in the main European countries, in Russia, other Central and Eastern European countries, Turkey, North Africa, the United States of America, Canada, Mexico and in some South American countries. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati was founded in 1926 and is based in Milan, Italy.


DEAL STATS #
Overall 14 of 17
Sector (Healthcare Services) 2 of 2
Type (Add-on Acquisition) 12 of 15
Country (Tunisia) 1 of 1
Year (2013) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-09 Laboratorios Casen Fleet S.L.U.

Pozuelo de Alarcón, Spain

Laboratorios Casen Fleet, S.L.U. is a Spanish pharmaceutical company.

Buy €93M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-31 Italchimici

Metropolitan City, Italy

Italchimici SpA is a pharmaceutical company. Italchimici’s wide-ranging product portfolio includes, among other brands, Reuflor, Peridon, Perido Natural and Lacdigest in the gastroenterological area and Aircort and Cexidal in the respiratory area.

Buy €130M

Seller(S) 1

SELLER

The Abraaj Group

Dubai, United Arab Emirates

Category Asset Manager
Founded 2002
PE ASSETS 7.4B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Abraaj Capital Limited is a private equity firm that seeks investments in the Middle East, North Africa, and South Asia. Abraaj looks for stable, mature businesses and uses a 'buy and build' strategy for growth. Areas of interest include aerospace, healthcare, transportation, financial services, leisure, education, energy, and manufacturing. In addition to its buyout and growth capital investments, Abraaj also invests in real estate and infrastructure. Abraaj Capital was formed in 2002 and is based in Dubai.


DEAL STATS #
Overall 10 of 30
Sector (Healthcare Services) 2 of 3
Type (Add-on Acquisition) 4 of 14
Country (Tunisia) 1 of 2
Year (2013) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-07 AIS GROUP

Abidjan, Cote D'Ivoire

AIS GROUP is an engineering services and component manufacturing and distribution company that provides end-to-end solutions for all engineering requirements, from the initial stages of identification of market requirements and conceptualization of component designs, to the manufacture and installation of tested products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-21 Yörükler Dış Ticaret A.Ş

Ankara, Turkey

Yörsan has been manufacturing branded dairy products in Turkey for over 50 years, during which time it has built high brand recognition and loyalty and has a market leading position in the higher value dairy segments. Yörsan has a strong portfolio of products covering all the main dairy categories of yoghurt, cheese, milk and the traditional Turkish drink - ayran. Yörsan’s dedication to high quality products, its modern production facility in Susurluk and its pan-national distribution network makes it one of the best positioned dairy manufacturers in the fast growing Turkish dairy industry.

Buy -